How Your Body Data Could Reshape Sectors

Aaron Wright, Morgan Stanley's US healthcare services analyst, discusses how proactive health tracking through wearables and direct-to-consumer lab testing is creating an investable theme. He estimates that expanded prevention could save $200B-$800B in healthcare costs by 2050, and outlines implications for consumer, fitness, and imaging sectors. - The shift from reactive to proactive healthcare is an investable theme. - Direct-to-consumer lab testing market is $4B and growing rapidly. - Wearables are used by 41% of respondents and drive behavior change. - Preventative testing could avoid $200B-$800B of US healthcare spend by 2050. - Health tracking may reshape consumer food choices toward functional benefits. - Fitness sector could benefit as gyms add wellness services. - Imaging is an emerging area for earlier disease detection. - Risks include out-of-pocket costs, privacy concerns, and inconsistent use.